Comparison Between Treatment Strategies of Carotid Stenosis in Patients Undergoing Coronary Artery Bypass Grafting.

Autor:	Bassan F; Coronary Artery Disease Department, Instituto Nacional de Cardiologia, Rio de Janeiro, Rio de Janeiro, Brazil., Azevedo VMP; Education & Research Department, Instituto Nacional de Cardiologia, Rio de Janeiro, Rio de Janeiro, Brazil., Santos AAAP; Education & Research Department, Instituto Nacional de Cardiologia, Rio de Janeiro, Rio de Janeiro, Brazil., Mello RB; Education & Research Department, Instituto Nacional de Cardiologia, Rio de Janeiro, Rio de Janeiro, Brazil., Verdolin AA; Education & Research Department, Instituto Nacional de Cardiologia, Rio de Janeiro, Rio de Janeiro, Brazil., Bassan R; Cardiology Department, Pontifícia Universidade Católica do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
Jazyk:	angličtina
Zdroj:	Brazilian journal of cardiovascular surgery [Braz J Cardiovasc Surg] 2022 May 23; Vol. 37 (3), pp. 315-320. Date of Electronic Publication: 2022 May 23.
DOI:	10.21470/1678-9741-2020-0425
Abstrakt:	Introduction: In patients undergoing coronary artery bypass grafting (CABG), stroke is a major complication that increases morbidity and mortality. The presence of carotid stenosis (CS) increases risk of stroke, and the optimal treatment remains uncertain due to the lack of randomized clinical trials. The aim of this study is to compare three management approaches to CS in patients submitted to CABG. Methods: From 2005 to 2015, 79 consecutive patients with significant CS submitted to CABG were retrospectively evaluated. Patients were divided in three groups, according to CS treatment: 17 underwent staged carotid endarterectomy (CEA)-CABG, 26 underwent synchronous CEA-CABG, and 36 underwent isolated CABG without carotid intervention. The primary outcomes were composed by 30-day postoperative acute myocardial infarction (MI), 30-day postoperative stroke, and death due to all causes during the follow-up. Results: Patients were evaluated during an average 2.05 years (95% confidence interval = 1.51-2.60) of follow-up. Major adverse cardiac events, including death, postoperative MI, and postoperative stroke, occurred in 76.5% of the staged group, 34.6% of the synchronous group, and 33.3% of the isolated CABG group (P=0.007). As for MI, the rates were 29.4%, 3.85%, and 11.1% (P=0.045), respectively. There was no statistically significant difference in total mortality rates (35.3%, 30.8%, and 25.0%, respectively; P=0,72) and stroke (29.4%, 7.7%, and 8.3%, respectively; P=0,064) between groups. Conclusion: Staged CEA-CABG is associated with higher major adverse cardiac events and MI rate when compared to the strategy of synchronous and isolated CABG, but without statistically difference in total mortality during the entire follow-up.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu